PM
CSII

Prosight Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Prosight Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-145,916
Closed -$1.99M – 54
2022
Q4 		$1.99M Buy
+145,916
New +$2.03M 1.08% 23

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Prosight Management's CSII Position: Q1 2023 in Review

Prosight Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 145,916 shares — an estimated $1.99M sold.

Prosight Management first reported a position in CSII in Q4 2022 and held it in 1 quarter. The position peaked at $1.99M in Q4 2022. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

  • Prosight Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
  • Prosight Management sold 145,916 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $1.99M.
  • Prosight Management first reported a position in Cardiovascular Systems, Inc. in Q4 2022 and held it in 1 quarter.
  • Prosight Management's Cardiovascular Systems, Inc. position peaked at $1.99M in Q4 2022.
  • 150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Prosight Management's 13F filing for Q1 2023, filed 12 May 2023.